AMERLITE TBG ASSAY

Radioimmunoassay, Thyroxine-binding Globulin

JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC.

The following data is part of a premarket notification filed by Johnson & Johnson Clinical Diagnostics, Inc. with the FDA for Amerlite Tbg Assay.

Pre-market Notification Details

Device IDK952284
510k NumberK952284
Device Name:AMERLITE TBG ASSAY
ClassificationRadioimmunoassay, Thyroxine-binding Globulin
Applicant JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC. 100 INDIGO CREEK DR. Rochester,  NY  14650 -0882
ContactYvonne E Middlefell
CorrespondentYvonne E Middlefell
JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC. 100 INDIGO CREEK DR. Rochester,  NY  14650 -0882
Product CodeCEE  
CFR Regulation Number862.1685 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1995-05-16
Decision Date1995-07-26

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.